CD33 and acute myeloid leukemia: PBMCs from AML patients were labeled with eFluor 450 tracking dye before overnight co-culture with BAT followed by staining for the remaining CD33+/CD123+ target cells expressing, leukemic blast, LSCs, and HSC populations in the co-culture compared to untreated PBMCs.